Intel (INTC) stock jumps after Nvidia closes $5 billion share purchase
30 December 2025
1 min read

Intel (INTC) stock jumps after Nvidia closes $5 billion share purchase

NEW YORK, December 30, 2025, 11:30 ET — Regular session

  • Intel shares rose about 4% in morning trading, bucking a softer tech backdrop.
  • A new filing confirmed Nvidia completed a $5 billion investment agreed in September.
  • Traders are also watching Fed minutes later Tuesday in thin year-end volumes.

Intel shares rose 3.8% to $38.08 in morning trade on Tuesday after the chipmaker confirmed Nvidia had completed a $5 billion stock purchase.

The transaction lands as Intel looks to reinforce its finances after years of missteps and capital-intensive production expansions, with the Nvidia investment seen as a key lifeline. 1

In a Form 8-K — a filing companies use to disclose material events between quarterly reports — Intel said it issued and sold 214,776,632 shares to Nvidia for $5.0 billion in cash, or $23.28 per share, and that the sale closed on Dec. 26. 2

The sale was structured as a private placement, meaning the shares were sold directly to a single investor rather than through a public offering.

That structure delivers cash quickly, but it also expands Intel’s share count. More shares outstanding can dilute earnings per share — profit divided by shares — if profits do not rise in step.

The backdrop for risk assets remained choppy. The S&P 500 and Nasdaq edged lower in thin holiday trading as investors waited for minutes from the Federal Reserve’s Dec. 9-10 meeting for clues on the pace of rate cuts in 2026. “You may have some repositioning… I wouldn’t try to make too much out of anything that happens in a holiday-shortened week,” said Art Hogan, chief market strategist at B Riley Wealth. 3

Nvidia, the dominant supplier of AI accelerators, was lower on the day even as Intel rose, highlighting the stock-specific nature of the move.

Intel’s filing said the transaction relied on a Securities Act exemption for deals not involving a public offering, a common legal route for private share sales.

Investors will now look for any clues on how Intel deploys the $5 billion and whether Nvidia’s equity stake leads to deeper operational ties beyond the investment already announced.

With U.S. markets closed Thursday for New Year’s Day, traders said lighter volumes can amplify moves and make price action harder to read.

Intel ended Monday at $36.68, up 1.3%, and remained about 17% below its $44.02 52-week high set on Dec. 3, according to MarketWatch data.

For the rest of the session, attention will stay on Fed minutes and interest-rate expectations, while Intel investors watch whether Tuesday’s jump holds after the initial reaction to the Nvidia filing fades.

Stock Market Today

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

7 February 2026
New York, Feb 7, 2026, 09:34 EST — Market closed. Alphabet’s non-voting Class C shares (GOOG) closed down 2.48% at $323.10 on Friday, extending a pullback after the Google parent flagged a sharp jump in spending tied to artificial intelligence. 1 With U.S. markets shut for the weekend, the near-term test is whether investors keep treating Big Tech’s AI build-out as a cost problem before it becomes a growth story. A Reuters review of the week’s trading showed fresh jitters around 2026 outlays across the sector, and SanJac Alpha chief investment officer Andrew Wells said the AI trade “got too
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Harmony Gold (HMY) stock rebounds in premarket as gold steadies after CME margin jolt
Previous Story

Harmony Gold (HMY) stock rebounds in premarket as gold steadies after CME margin jolt

Canada’s 2026 TFSA limit is $7,000 as tax brackets rise: key CRA dates ahead
Next Story

Canada’s 2026 TFSA limit is $7,000 as tax brackets rise: key CRA dates ahead

Go toTop